BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation

Data ReadoutpositiveDeep TMSPositive

AI Analysis

Summary

BrainsWay's peer-reviewed secondary analysis of Deep TMS demonstrates 70% reduction in suicidal ideation among major depressive disorder patients, adding to clinical evidence supporting the treatment's potential.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

70% reduction in patients experiencing suicidal ideation

Importance:6/10

Sentiment:

0.75

Deep TMSsuicidal ideationmajor depressive disordersecondary analysisclinical evidence

Related Companies

$BWAY

Read the original article

Published by GlobeNewswire Clinical Studies on August 27, 2026 11:30 AM

Read Original